Table of Contents
Overview
Definition of Pharmacology
Pharmacology is defined as the scientific discipline that studies the effects of drugs on living systems, encompassing their origins, chemical properties, biological effects, and therapeutic uses. It examines how drugs interact with biological targets, focusing on both the actions of drugs on the body (pharmacodynamics) and the body's processing of drugs (pharmacokinetics).[4.1] The term pharmacology is derived from the Greek words "pharmakon," meaning drug or poison, and "logos," meaning study or discourse.[8.1] Pharmacology is the scientific discipline that studies how drugs interact with living systems, focusing on their sources, chemical properties, biological effects, and therapeutic uses.[3.1] It encompasses various subfields, including pharmacodynamics, which examines the actions of drugs on the body, and pharmacokinetics, which investigates the fate of drugs within the body.[4.1] Additionally, pharmacology overlaps with pharmacy, the science concerned with the preparation and dispensing of medications, and it plays a significant role in pharmacotherapeutics, which is the treatment of diseases.[4.1] The field also includes safety pharmacology, which specializes in detecting and investigating potential undesirable effects of drugs.[5.1] Furthermore, pharmacology is integral to drug design and development, beginning with the inventive process of drug discovery, where molecules are designed to interact with specific biomolecular targets.[5.1] Pharmacology is defined as the science of drugs and medications, focusing on their origin, composition, pharmacokinetics, pharmacodynamics, therapeutic use, and toxicology.[5.1] This field encompasses various subfields, including drug design and development, which begins with the inventive process of identifying new drugs through the design of molecules that interact effectively with specific biomolecular targets.[5.1] The historical development of pharmacology has evolved from early medicinal practices to its establishment as a scientific discipline, highlighting the contributions of key figures and the social and political implications of scientific inquiry in medicine.[9.1] Since the mid-20th century, pharmacological research has led to the creation of a wide array of new therapeutic agents, including antibiotics like penicillin and hormonal drugs such as insulin and cortisone.[6.1] Overall, pharmacology plays a crucial role in understanding drug interactions with living systems, ultimately aiming to enhance therapeutic outcomes and patient care.[6.1]Importance in Medicine
Pharmacogenomics plays a crucial role in the advancement of personalized medicine, which aims to tailor medical treatment to the individual characteristics of each patient. This field significantly impacts drug prescription and dosing, although its benefits are currently accessible to only a small segment of the global population.[15.1] The essence of pharmacogenomics lies in understanding how genetic variations influence drug response, which is essential for developing guidelines and clinical applications for medications.[16.1] The concept of personalized medicine, often referred to as precision medicine, integrates genetic, environmental, and lifestyle factors to prescribe the most appropriate medications for patients.[16.1] Pharmacogenomics is recognized as a core element of this approach, as it addresses the interindividual variability in drug response stemming from multiple factors, including genomics, epigenomics, and patient-specific characteristics such as age and gender.[17.1] By leveraging pharmacogenomic data, healthcare providers can enhance treatment efficacy by identifying the most effective medications for individual patients, thereby improving overall treatment outcomes.[18.1] The historical context of personalized medicine highlights significant milestones in genetics and technology that have shifted healthcare from a generalized approach to one that emphasizes individualized treatment strategies.[19.1] Advances in genomics and biotechnology have facilitated the prediction of disease risks and the tailoring of treatments to align with individual genetic profiles, thereby enhancing precision in diagnosis and management.[19.1] Pharmacogenomics also emphasizes the importance of accurately predicting an individual's response to medications, as both genetic and environmental factors contribute to drug response variability.[20.1] This field of study, which examines genetic influences on drug response, has gained momentum since the sequencing of the human genome, leading to a deeper understanding of how genetic variations can affect treatment outcomes.[27.1]In this section:
History
Ancient Civilizations and Herbal Medicine
The Ebers Papyrus, dated around 1550 BCE, is one of the oldest known medical texts and is recognized as the most extensive surviving medical document from ancient Egypt, containing over 800 prescriptions that address a variety of ailments, including digestive disorders and respiratory issues such as asthma.[53.1] This papyrus reflects the strong connection between medicine and religion in ancient Egypt, where many treatments were intertwined with spiritual and magical practices.[51.1] It includes approximately 700 magical formulas and folk remedies aimed at curing afflictions ranging from crocodile bites to toenail pain, illustrating the holistic approach to health that characterized the medical practices of that time.[52.1] The influence of Egyptian medical practices extended to later cultures, notably impacting Greek and Roman physicians.[53.1] Ancient civilizations such as Egypt, Mesopotamia, China, and India laid the groundwork for modern pharmacology through their reliance on herbal remedies and natural substances to address various ailments and diseases. Notable plants used for medicinal purposes included aloe vera, garlic, and opium poppy, which were integral to their healing practices.[61.1] Additionally, natural clays and minerals were employed for their absorbent, antimicrobial, and detoxifying properties, with ancient cultures incorporating these materials into both medicinal and cosmetic applications to cleanse wounds, soothe skin conditions, and support gastrointestinal health.[62.1] In India, the Ayurvedic system emerged as a holistic approach to medicine, emphasizing the balance of mind, body, and spirit. Key texts such as the Charaka Samhita and the Sushruta Samhita outlined principles of diagnosis, treatment, and prevention, which included herbal remedies, dietary guidelines, and yoga practices.[64.1] The contributions of these ancient civilizations continue to influence contemporary healthcare and wellness practices, highlighting the enduring legacy of their medicinal knowledge. The Greek contributions to pharmacology were also notable, particularly through the works of Hippocrates and Galen. Hippocratic medicine emphasized rational observation and naturalistic explanations for diseases, laying the groundwork for clinical practices that would influence future generations.[64.1] The legacy of these ancient practices not only shaped early pharmacological theories but also continues to inform modern approaches to healthcare and wellness, highlighting the enduring significance of herbal medicine in the evolution of pharmacology.[63.1]Development of Modern Pharmacology
The development of modern pharmacology can be traced back to significant advancements made during the 19th century, which marked a transition from traditional herbal remedies to a more scientific approach to drug development. This period saw the establishment of pharmacology as a distinct biomedical science that utilized scientific experimentation to explore therapeutic contexts. The introduction of innovative research techniques, such as the organ bath preparation, allowed for the physiological responses of tissue samples to be recorded, thereby enhancing the understanding of drug effects.[41.1] One of the pivotal figures in this transformation was Rudolf Buchheim, who is credited with founding experimental pharmacology as an independent medical discipline. He introduced animal experiments to study drug mechanisms and was the first to classify drugs based on their mode of action, laying a more natural scientific foundation for pharmacology.[45.1] This shift towards experimental methods was complemented by significant medical discoveries, including the development of anesthesia, which revolutionized surgical practices and highlighted the importance of pharmacological research.[42.1] The latter half of the 19th century also witnessed the extraction of key compounds from natural sources, such as cocaine from coca leaves in 1860 and salicylic acid from willow bark in 1874, which later became the precursor to aspirin. These discoveries not only enriched the pharmacopoeia but also underscored the growing reliance on empirical evidence in drug development.[44.1] As pharmacology progressed into the 20th century, the field experienced a rapid expansion with the introduction of synthetic drugs and biopharmaceuticals. This era was characterized by significant advancements in drug safety and efficacy testing, particularly following World War II, when the pharmaceutical industry saw a surge in new drug approvals, including antibiotics like penicillin.[48.1] However, this period was also marked by ethical challenges, notably the thalidomide tragedy, which prompted stricter regulations and oversight in clinical trials. The consequences of thalidomide, which caused severe birth defects when prescribed to pregnant women, highlighted the need for rigorous drug safety monitoring and established the foundations for modern pharmacovigilance.[58.1]Branches Of Pharmacology
Pharmacokinetics
Pharmacokinetics (PK) is a critical branch of pharmacology that focuses on the absorption, distribution, metabolism, and excretion (ADME) of drugs within the body. Understanding pharmacokinetics is essential for optimizing drug therapies, as it allows healthcare providers to tailor treatments based on individual patient characteristics, such as age, weight, and metabolic function.[86.1] Variations in pharmacokinetics and pharmacodynamics between children and adults can significantly influence drug dosing and effectiveness across different patient populations. Many physiological differences, such as gastric pH, emptying time, and intestinal transit time, contribute to age-related changes in pharmacokinetics, which can affect the oral bioavailability of medications in pediatric populations.[88.1] Additionally, the pharmacokinetics of many drugs vary with age, as rapid changes in size, body composition, and organ function occur, particularly during the first year of life.[89.1] Studies have demonstrated that pharmacokinetic parameters, including half-life, apparent volume of distribution, and total plasma clearance, differ among various age groups, highlighting the necessity for tailored dosing strategies in children.[87.1] In older adults, age-related changes in organ function and body composition can alter pharmacokinetics, affecting drug distribution and elimination. For example, a decrease in total body water and an increase in body fat can modify the volume of distribution for many medications, which may require careful consideration of dosing to avoid adverse effects.[91.1] Additionally, the first-pass effect can necessitate multiple doses of oral medications to achieve therapeutic levels in circulation, further complicating dosing regimens.[93.1] Pharmacokinetic interactions between drugs can also influence their efficacy and safety profiles. Changes in absorption, distribution, metabolism, or excretion due to drug-drug interactions can lead to altered drug exposure and subsequent pharmacodynamic effects.[94.1] Population pharmacokinetics, which analyzes drug concentration data from diverse individuals, helps identify variability in drug response related to factors such as age, gender, and disease state, thereby informing population-specific dosing recommendations.[95.1]Pharmacodynamics
Pharmacodynamics is a critical branch of pharmacology that focuses on the effects of drugs on the body, encompassing the relationship between drug concentration and therapeutic response. It is essential for understanding how drugs exert their effects, which is influenced by various factors such as receptor sensitivity, drug concentration, and individual patient variability.[98.1] The magnitude and duration of a drug's therapeutic and adverse effects are determined by its pharmacodynamic properties, which describe how the drug interacts with biological systems.[99.1] The interplay between pharmacodynamics and pharmacokinetics—often summarized as "what the drug does to the body" versus "what the body does to the drug"—is vital for optimizing drug therapies. Pharmacokinetics involves the study of drug absorption, distribution, metabolism, and excretion (ADME), which are crucial for predicting drug concentrations at the site of action and understanding factors that influence drug bioavailability.[102.1] By integrating knowledge of both pharmacodynamics and pharmacokinetics, healthcare providers can customize treatments to achieve optimal therapeutic outcomes while minimizing side effects.[98.1] In clinical practice, the principles of pharmacodynamics are applied to determine the appropriate dosing regimens and to assess the therapeutic effects of medications. For instance, due to the first-pass effect, multiple doses of an oral medication may be necessary to maintain sufficient levels of the active drug in circulation to achieve the desired therapeutic effect.[97.1] Additionally, pharmacodynamics plays a role in understanding how certain drugs may inhibit enzymes, thereby affecting the sensitivity of patients to other medications metabolized through those enzymes.[97.1]Recent Advancements
Role of Artificial Intelligence in Drug Development
Artificial intelligence (AI) has emerged as a transformative force in drug development, significantly enhancing the efficiency, accuracy, and speed of the drug discovery process. By leveraging machine learning (ML) and deep learning (DL) techniques, AI facilitates the analysis of extensive datasets, enabling the identification of patterns that are crucial for disease identification, drug discovery, and clinical trial management.[128.1] The integration of AI into drug discovery processes allows for improved decision-making across various applications, such as quantitative structure-activity relationship (QSAR) analysis, hit discovery, and the design of novel drug architectures.[126.1] AI's capabilities extend to critical stages of drug development, including target discovery and validation, small molecule drug design, and the acceleration of clinical trials.[127.1] However, the application of AI in this field is not without challenges. Issues such as the need for robust data-sharing mechanisms and comprehensive intellectual property protections for algorithms must be addressed to fully realize AI's potential in drug development.[127.1] Moreover, AI-based approaches can enhance the overall drug discovery process by optimizing the identification of drug targets and predicting druggability, particularly in complex diseases like cancer, where traditional methods often fall short.[130.1] For instance, PaccMann, an AI-driven framework, exemplifies how biological data can be integrated to predict cancer cell sensitivity to various compounds, thereby improving the drug identification process.[130.1] Recent advancements in AI, including data augmentation and explainable AI, further promise to overcome existing limitations in drug discovery, allowing for a more effective collaboration between AI technologies and human researchers.[129.1] This synergy is expected to lead to the development of more effective medications, ultimately revolutionizing the landscape of pharmacology.[129.1]Innovations in Drug Discovery
Recent advancements in pharmacology have significantly transformed the landscape of drug discovery, particularly through the integration of personalized medicine and genomics. Advances in pharmacology research are leading to the development of a new generation of medicines that are not only more effective but also more targeted and personalized. This evolution is largely driven by an enhanced understanding of molecular biology, genetics, and disease mechanisms, which are crucial in addressing complex health challenges.[115.1] The history of personalized medicine illustrates a shift from a one-size-fits-all approach to a more individualized understanding of health and disease. This transition has been marked by significant milestones in genetics and technology, particularly in the 21st century, which have enabled more personalized approaches to medicine. These advancements allow for the prediction of disease risks and the tailoring of treatments to individual genetic profiles, thereby enhancing precision in diagnosis and treatment strategies.[116.1] Genomics plays a pivotal role in personalized medicine by analyzing an individual’s genetic information to predict disease susceptibility and determine optimal treatment strategies. A key aspect of this field is pharmacogenomics, which examines the relationship between genetic variations and drug responses. By considering individual patient characteristics, including genetic variations, biomarkers, and clinical data, personalized medicine aims to optimize treatment efficacy, minimize adverse effects, and improve patient outcomes across various medical fields.[120.1] As the integration of genetic profiling continues to evolve, it is expected to further refine drug discovery processes, enabling the development of tailored treatment approaches based on individual patient characteristics. However, challenges remain in implementing personalized medicine on a broader scale, including the need for comprehensive genetic databases and the standardization of genetic testing protocols.[120.1]In this section:
Ethical And Regulatory Challenges
Pharmacovigilance
Pharmacovigilance is a critical aspect of pharmaceutical regulatory compliance, which involves adherence to guidelines, laws, and standards established by regulatory authorities such as the FDA (U.S.), EMA (Europe), and CDSCO (India).[145.1] The primary aim of these regulations is to protect public health by ensuring that pharmaceutical products meet stringent safety and quality criteria.[145.1] Through effective pharmacovigilance practices, the safety and efficacy of drugs are monitored systematically after their approval, which is essential for identifying and evaluating any adverse drug reactions.[145.1] This ongoing assessment helps to ensure that the benefits of medications continue to outweigh their associated risks, thereby reinforcing the importance of pharmacovigilance in the healthcare system.[145.1] One of the primary challenges in pharmacovigilance is the complexity of obtaining informed consent from participants in clinical trials, particularly among vulnerable populations with limited health literacy. This complexity raises ethical concerns regarding whether participants are adequately informed about the risks and benefits associated with the drugs being tested.[153.1] Furthermore, ethical decision-making in pharmacovigilance must balance profit motives with patient welfare, as pharmaceutical companies often face dilemmas related to drug pricing and accessibility. These dilemmas can create tensions between the need to recover research and development costs and the obligation to ensure that essential treatments are affordable for patients.[160.1] The ethical challenges in pharmacovigilance also extend to the handling of adverse events and the use of placebos in clinical trials. Researchers must navigate these dilemmas while ensuring that patient safety remains a top priority. Continuous vigilance from all stakeholders, including clinical research staffing agencies, is necessary to equip research teams with the knowledge and resources to address these ethical challenges effectively.[161.1] As the landscape of pharmacological research evolves, the integration of robust pharmacovigilance practices will be vital in maintaining public trust and ensuring that new therapies do not compromise patient safety.Access and Distribution Issues
Access to medications and their equitable distribution are critical ethical challenges within the pharmaceutical industry. The principles of beneficence, non-maleficence, justice, and autonomy, as articulated in the Declaration of Geneva in 1948, underscore the importance of ensuring that all individuals have access to necessary medications while also considering the ethical implications of drug pricing and accessibility.[149.1] The COVID-19 pandemic has further highlighted the necessity of trust between pharmaceutical experts and the public, emphasizing that ethical interventions are essential for maintaining this trust and ensuring equitable access to medications.[150.1] The pharmaceutical industry faces significant ethical dilemmas, particularly regarding drug pricing and accessibility, which create a conflict between the need for companies to recover research and development costs and the ability of patients to afford essential treatments.[151.1] Ethical decision-making in this sector is critical for balancing profit motives with patient welfare and public health concerns, as the industry grapples with complex challenges involving financial interests, drug pricing, patent protections, and marketing practices.[151.1] Furthermore, public health powers and responsibilities in the U.S. derive from the Constitution and are shared across federal, state, and local levels of government, each with unique roles that can vary significantly.[154.1] This "patchwork" system of public health efforts, which includes both governmental and private actors, underscores the complexities involved in addressing disparities in access to medications among different socioeconomic groups.[154.1] Pharmacies often serve as the first point of access to healthcare in many communities, especially in underserved areas. However, barriers such as pharmacy deserts—regions with limited or no access to pharmacies—significantly impact marginalized groups, leading to health disparities.[155.1] As healthcare providers increasingly recognize the importance of pharmacoequity, addressing these barriers becomes crucial for improving health outcomes and ensuring that all individuals can access necessary medications.[155.1] Public health advocacy is a critical component in addressing health disparities and promoting overall community well-being, particularly for marginalized communities.[157.1] These advocacy efforts must navigate complex ethical considerations that arise in the context of public health social work and policy advocacy.[157.1] To assess the ethics of public health interventions effectively, it is essential to determine the public health goals of the proposed actions, identify relevant facts and uncertainties, and analyze the implications for the health and rights of affected individuals and communities.[158.1] Furthermore, public policy advocacy is rooted in values and political determinants of public health, making it an essential tool for protecting and improving community health.[159.1]In this section:
Applications In Clinical Practice
Personalized Medicine
Personalized medicine represents a crucial advancement in the field of pharmacology, which plays a vital role in modern medicine, encompassing drug discovery and clinical applications. By understanding the genetic basis of drug response, healthcare providers can tailor drug therapies to individual patients, thereby optimizing treatment efficacy and minimizing adverse drug reactions (ADRs).[166.1] The significance of pharmacology in drug development and safety, as well as in personalized medicine, cannot be overstated.[168.1] As our comprehension of the mechanisms of drug action and interactions continues to evolve, the role of pharmacology in medicine will also advance, further enhancing the potential of personalized medicine.[168.1] Pharmacogenomics, a critical component of personalized medicine, utilizes a patient's genomic information to guide medication selection and dosing. This field combines pharmacology and genomics to analyze how genetic variations affect drug metabolism and response.[170.1] For instance, pharmacogenomic testing can identify specific genomic variants that may influence a patient's reaction to medications, allowing for more tailored and effective treatment plans.[171.1] The application of pharmacogenomics has shown promising results in various clinical settings. For example, studies have indicated that patients receiving genotype-guided treatment for antidepressants demonstrated significantly better outcomes in terms of response and remission rates compared to those under standard clinical management.[172.1] Furthermore, the Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment (PREDICT) program highlighted that a substantial percentage of preemptively genotyped patients had actionable variants, underscoring the potential of pharmacogenomics to improve patient care.[172.1] Despite the advancements, challenges remain in integrating pharmacogenomic testing into routine clinical practice. Many healthcare providers may lack confidence in ordering such tests, and there is often insufficient evidence or training available to support their use.[173.1] Additionally, while recent revisions to drug labels by the FDA have included pharmacogenetic information, genetic testing is not universally mandated before initiating therapy, which can limit the full benefits of personalized medicine.[173.1]Drug Interaction Management
Drug interaction management is a critical aspect of pharmacology that ensures the safe and effective use of medications in clinical practice. The literature reviewed for the concept analysis highlights that implementation in healthcare settings, particularly in clinical healthcare delivery systems, is essential for managing drug interactions effectively. This implementation encompasses several domains, including the characteristics of practice change, the guidelines or evidence that inform these changes, strategies for implementing interventions, and the challenges faced in overcoming barriers to effective management.[178.1] In the realm of drug interaction management, the concept of implementation is pivotal across various healthcare settings, particularly in clinical healthcare delivery systems, quality improvement, and patient safety initiatives.[178.1] The literature reviewed for this concept analysis identifies four essential domains within the construct of implementation: first, the characteristics of practice change; second, the guidelines or other forms of evidence that should inform these practice changes; third, the strategies necessary to implement an intervention or clinical practice guideline; and fourth, the challenges that may arise, along with potential interventions to address these barriers.[178.1] Understanding these domains is crucial for healthcare providers as they work to enhance patient safety and improve clinical outcomes through effective management of drug interactions.[178.1] The implementation of drug interaction management strategies is essential across various healthcare settings, particularly in clinical healthcare delivery systems, quality improvement, and patient safety initiatives.[178.1] The literature identifies four critical domains within the construct of implementation: 1) the characteristics of practice change; 2) the guidelines or other forms of evidence that should inform these practice changes; 3) strategies for implementing interventions or clinical practice guidelines; and 4) the challenges that may arise, along with potential interventions to address these barriers.[178.1] Understanding these domains is vital for enhancing the effectiveness of drug interaction management and promoting patient safety in clinical practice.[178.1]In this section:
Future Directions
Emerging Trends in Pharmacology
Recent advancements in pharmacology are significantly influenced by the integration of artificial intelligence (AI) and machine learning (ML), which are transforming various stages of drug discovery and development. These technologies enhance the efficiency and precision of clinical trials by enabling faster patient recruitment, real-time data analysis, and more personalized treatment approaches. AI and ML streamline complex tasks such as patient selection, trial monitoring, and data analysis, thereby improving the overall safety and outcomes of clinical trials.[190.1] Furthermore, AI-driven methods can mitigate challenges in drug development, particularly in cancer treatment, by improving target identification and predicting druggability through the analysis of multiomics data.[191.1] In addition to AI and ML, advancements in drug delivery systems are reshaping the landscape of pharmacology. The convergence of these technologies with advanced materials science has led to the development of innovative drug delivery systems, such as nanocarriers, hydrogels, and bioresponsive polymers. These systems are designed to be adaptive, altering their properties in response to biological stimuli, which enhances their efficiency and patient specificity.[192.1] Nanotechnology, in particular, has revolutionized drug delivery by enabling site-specific and target-oriented delivery of therapeutics, thus improving treatment efficacy while minimizing side effects.[195.1] Nanomedicine, a burgeoning field within pharmacology, leverages the unique properties of nanomaterials to advance drug delivery, diagnostics, and therapeutic interventions. This includes the use of various nanomaterials, such as metal-based, carbon-based, and organic compounds, which have shown promise in enhancing drug solubility and targeting specific cells.[196.1] The impact of nanotechnology extends to public health applications, where it has facilitated the development of rapid diagnostics and effective therapeutics, particularly during health crises like the COVID-19 pandemic.[194.1]In this section:
References
[3] What is Pharmacology? An introduction | Pharmacology Mentor — Introduction. Pharmacology is the scientific discipline that studies how drugs interact with living systems, focusing on the sources, chemical properties, biological effects, and therapeutic uses of different pharmacological agents.By exploring the mechanisms by which medications influence the body, pharmacology provides essential insights that form the basis of therapeutic interventions and
[4] Introduction and Scope of Pharmacology - The Pharmapedia — Principles of Pharmacology. Pharmacology (Gr. pharmakon - a drug or poison, logos - word or discourse) is the science dealing with actions of drugs on the body (pharmacodynamics) and the fate of drugs in the body (pharmacokinetics).It overlaps with pharmacy, the science of preparation of drugs; much of it deals with therapeutics (Pharmacotherapeutics), the treatment of disease.
[5] Pharmacology - Wikipedia — Pharmacology is the science of drugs and medications, including a substance's origin, composition, pharmacokinetics, pharmacodynamics, therapeutic use, and toxicology. It encompasses the subfields of drug design and development. Drug discovery starts with drug design, which is the inventive process of finding new drugs. In the most basic sense, this involves the design of molecules that are complementary in shape and charge to a given biomolecular target. After a lead compound has been identified through drug discovery, drug development involves bringing the drug to the market. Drug discovery is related to pharmacoeconomics, which is the sub-discipline of health economics that considers the value of drugs Pharmacoeconomics evaluates the cost and benefits of drugs in order to guide optimal healthcare resource allocation. The techniques used for the discovery, formulation, manufacturing and quality control of drugs discovery is studied by pharmaceutical engineering, a branch of engineering. Safety pharmacology specialises in detecting and investigating potential undesirable effects of drugs.
[6] Pharmacology | Drug Development, Clinical Trials & Therapeutics ... — Pharmacology | Drug Development, Clinical Trials & Therapeutics | Britannica Ask the Chatbot Games & Quizzes History & Society Science & Tech Biographies Animals & Nature Geography & Travel Arts & Culture ProCon Money Videos pharmacology, branch of medicine that deals with the interaction of drugs with the systems and processes of living animals, in particular, the mechanisms of drug action as well as the therapeutic and other uses of the drug. In the 20th century, and particularly in the years since World War II, pharmacological research has developed a vast array of new drugs, including antibiotics, such as penicillin, and many hormonal drugs, such as insulin and cortisone.
[8] A brief history of pharmacology - American Chemical Society — This article briefly presents the historical development of pharmacology and some of the basic methods used.Etymologically, pharmacology is the science of drugs (Greek pharmakos, medicine or drug; and logos, study). Amoxicillin inhibits the synthesis of cell wall mucopeptide by the bacteria that cause the infection, and cimetidine inhibits gastric acid secretion by its antagonist action on histamine H2 receptors.The main tasks of pharmacologists in the search for and development of new medicines arescreening for desired activity,determining mode of action, andquantifying drug activity when chemical methods are not available.Historical developmentSynthetic organic chemistry was born in 1828, when Friedrich Wohler synthesized urea from inorganic substances and thus demolished the vital force theory.
[9] A brief history of pharmacology, therapeutics and scientific thought — This article explores the historical development of pharmacology, tracing its roots from early medicinal practices to the establishment of pharmacology as a scientific discipline. It emphasizes the contributions of key figures and the social and political implications of scientific inquiry in the field of medicine.
[15] The Impact of Pharmacogenomics in Personalized Medicine — Pharmacogenomics has played a very important role in adopting the goal of personalized medicine for many diseases. It has greatly impacted the prescription of a drug and its dose for many diseases, but a small population of the world can enjoy the benefits of Pharmacogenomics.
[16] The role of pharmacogenomics in precision medicine — 4. Discuss the role pharmacogenomics has played in developing guidelines and clinical applications of drugs. Personalized medicine, often called precision medicine, is a medical practice in which patients are prescribed medications that are appropriate to them, based on their genetic, environmental, and lifestyle factors.
[17] Pharmacogenomics: a key component of personalized therapy — Pharmacogenomics is one of the core elements in personalized medicine. The basic concept is that interindividual variability in drug response is a consequence of multiple factors, including genomics, epigenomics, the environment and a patient's characteristics, such as gender, age and/or concomitant medication [ 1 ].
[18] PDF — Benefits of Pharmacogenomics in Personalized Medicine Enhanced Efficacy Pharmacogenomics facilitates the identification of the most effective medications for individual patients. By understanding a patient's genetic profile, healthcare providers can select drugs that are more likely to be effective, thus improving treatment outcomes.
[19] Revolutionizing Personalized Medicine: Synergy with Multi-Omics Data ... — The history of personalized medicine is punctuated by significant milestones in genetics, technology, and clinical applications, shifting healthcare from a one-size-fits-all approach to a more individualized understanding of the molecular basis of health and disease and effective treatment strategies . Advances in genomics and biotechnology in the 21st century are enabling more personalized approaches to medicine, predicting disease risks, and tailoring treatments to individual genetic profiles. Personalized medicine leverages these images in conjunction with genetic data to gain deeper insights into disease mechanisms in individual patients, enhancing precision in diagnosis and treatment strategies . Through the integration of genetic, molecular, and clinical data, personalized medicine enables more accurate diagnosis, precise treatment targeting, and effective disease management.
[20] Cardiovascular pharmacogenomics and individualized drug therapy - PMC — The goal of individualized drug therapy requires physicians to be able to accurately predict an individual's response to a drug. Both genetic and environmental factors are known to influence drug response. 'Pharmacogenetics' is the study of the role of inheritance in variation in drug response phenotypes.
[27] PHARMACOGENOMICS AND PHARMACOGENETICS - Understanding Genetics - NCBI ... — The impact of genetic makeup on drug response and outcome has been known since the 1950s. Interest reignited with the sequencing of the human genome, leading to the field now commonly known as pharmacogenomics. Genetic variation in drug targets or genes involved in drug disposition are known to result in different drug responses and outcomes for a given group of patients treated with the same
[41] History of Pharmacology - Pharmaceuticals Index — Pharmacology developed in the 19th century as a biomedical science that applied the principles of scientific experimentation to therapeutic contexts. The advancement of research techniques propelled pharmacological research and understanding. The development of the organ bath preparation, where tissue samples are connected to recording devices, such as a myograph, and physiological responses
[42] REvolutionary MEDICAL DISCOVERIES: 19th Century BREAKTHROUGHS! — What were the medical discoveries made during the 19th century? During the 19th century, there were several significant medical discoveries that revolutionized the field of medicine.. Anesthesia: One of the most important medical discoveries of the 19th century was the development and use of anesthesia. In 1846, William Morton demonstrated the successful use of ether as an anesthetic during
[44] The Pharmaceutical Century - 1800 to 1919 - UAH — Staging the Pharmaceutical Century In the latter half of the 19th century, numerous beneficent botanicals took center stage in the world's pharmacopoeias. Cocaine was first extracted from coca leaves in 1860; salicylic acid—the forerunner of aspirin—was extracted from willow bark in 1874 for use as a painkiller.
[45] The Great Pharmacologists and Their Revolutionary Discoveries - Springer — 1.2.2 Rudolf Buchheim (1820, Bautzen, Germany-1879, Giessen, Germany) (Fig. 1.2). Rudolf Buchheim introduced animal experiments (Experimental Pharmacology) and worked on the mechanisms of drug effects, thereby a more natural scientific basis for the pharmaceutics (drugs) heralded.He was the first to classify drugs based on their mode of action - called the "natural system of drugs."
[48] A Brief History Of Drug Development In The United States — The mid-20th century saw significant advances in medical science and drug development. Following World War II, the pharmaceutical industry entered a period of rapid growth, with many new drugs hitting the market. The introduction of antibiotics, such as penicillin, revolutionized the treatment of bacterial infections, saving countless lives.
[51] Ancient Egypt's Guide to Healing and Medicine: The Ebers Papyrus — The papyrus also reflects the strong connection between medicine and religion in ancient Egypt, where many treatments were intertwined with spiritual and magical practices. Examples of remedies in the Ebers Papyrus. 1. Treatment for Asthma: One of the remedies in the Ebers Papyrus describes a treatment for asthma, which involved inhaling the
[52] Ebers papyrus | Ancient Medicine, Medical Treatments & Herbal Remedies ... — Ebers papyrus, Egyptian compilation of medical texts dated about 1550 bc, one of the oldest known medical works.The scroll contains 700 magical formulas and folk remedies meant to cure afflictions ranging from crocodile bite to toenail pain and to rid the house of such pests as flies, rats, and scorpions.
[53] Ancient Egyptian Medicine - World History Edu — The Ebers Papyrus (c. 1550 BCE) - The most extensive surviving medical document, containing over 800 prescriptions and discussing ailments such as digestive disorders, ... Legacy and Influence on Later Medicine. Egyptian medical practices influenced Greek and Roman physicians,
[58] The Evolution of Good Clinical Practices: A Historical Perspective — In the late 1950s and early 1960s, the thalidomide tragedy shook the world and highlighted the dire consequences of inadequate oversight in drug development and clinical trials. Thalidomide, a sedative drug prescribed to pregnant women for morning sickness, was later found to cause severe birth defects in thousands of children worldwide.
[61] The Evolution of Pharmaceuticals: From Ancient Remedies to Modern — The roots of pharmaceuticals can be traced back to ancient civilizations such as Egypt, Mesopotamia, China, and India. These cultures relied on herbal remedies and natural substances to treat various ailments and diseases. Plants like aloe vera, garlic, and opium poppy were among the many botanical sources used for medicinal purposes
[62] Ancient Remedies: Natural Pathways to Modern Wellness — Natural clays and minerals have long been used in therapeutic practices for their absorbent, antimicrobial, and detoxifying properties. Ancient civilizations, including the Egyptians, Greeks, and Chinese, incorporated these substances into medicinal and cosmetic applications to cleanse wounds, soothe skin conditions, and aid gastrointestinal
[63] The Evolution of Pharmacology: From Ancient Herbs to Biopharma — The Evolution of Pharmacology: From Ancient Herbs to Biopharma - BiologyInsights Explore the journey of pharmacology's transformation from ancient herbal remedies to cutting-edge biopharmaceutical advancements. This article will explore pivotal moments that have shaped the field, beginning with ancient practices and moving through alchemical and renaissance contributions to modern advancements in synthetic drugs and biotechnology. The roots of pharmacology can be traced back to ancient civilizations, where the use of herbs and plants for medicinal purposes was common. The rediscovery and translation of ancient texts, coupled with innovative research, provided fertile ground for pharmacological progress. The 19th and 20th centuries heralded a new era in pharmacology with the advent of synthetic drugs, transforming the landscape of medicine.
[64] The evolution of ancient healing practices: From shamanism to ... — Similarly, in ancient India, Ayurveda emerged as a holistic system of medicine, emphasizing the balance of mind, body, and spirit. Ayurvedic texts, such as the Charaka Samhita and the Sushruta Samhita, detailed diagnosis, treatment, and prevention principles, including herbal remedies, dietary guidelines, and yoga practices. The ancient Greeks, particularly during the Classical period, made significant contributions to the development of medical science through the work of physicians like Hippocrates and Galen. Hippocratic medicine, named after the renowned physician Hippocrates, emphasized rational observation, naturalistic explanations for disease, and ethical principles guiding medical practice. The Hippocratic Corpus, a collection of texts attributed to Hippocrates and his followers, laid the foundation for clinical medicine, advocating for the systematic study of symptoms, prognosis, and treatment outcomes. Galen, a prominent physician of the Roman Empire, further expanded upon Hippocratic teachings, contributing to advancements in anatomy, physiology, and pharmacology. The legacy of ancient healing practices extends far beyond historical curiosity, influencing contemporary approaches to healthcare and wellness.
[86] Pharmacokinetics vs Pharmacodynamics: Key Differences | KCAS Bio — By understanding both pharmacokinetics and pharmacodynamics, drug development companies can optimize drug therapies for maximum efficacy and minimal side effects. Despite these differences, pharmacokinetics and pharmacodynamics work well together in drug development. By understanding how individuals may metabolize drugs differently (pharmacokinetics) and how their bodies might respond to these drugs (pharmacodynamics), healthcare providers can customize treatments for optimal outcomes. Understanding the interplay between pharmacokinetics and pharmacodynamics is crucial for developing safe and effective drugs. Pharmacodynamics (PD) describes how drugs affect the body, influenced by factors like receptor sensitivity, drug concentration, and patient variability. Pharmacokinetics (PK) is influenced by factors like age, weight, metabolism, and liver function, which affect drug absorption, distribution, metabolism, and excretion.
[87] Developmental Pharmacokinetics in Pediatric Populations — These studies have demonstrated the existence of many pharmacokinetic and some pharmacodynamic differences among the pediatric population.5 6 Traditional studies demonstrated that pharmacokinetic parameters including half-life, apparent volume of distribution (Vd), and total plasma clearance vary among different age groups even when normalized
[88] Factors and Mechanisms for Pharmacokinetic Differences between ... — Abstract. Many physiologic differences between children and adults may result in age-related changes in pharmacokinetics and pharmacodynamics. Factors such as gastric pH and emptying time, intestinal transit time, immaturity of secretion and activity of bile and pancreatic fluid among other factors determine the oral bioavailability of pediatric and adult populations.
[89] Pharmacokinetics and Pharmacodynamics in Children versus Adults — Pharmacokinetics and pharmacodynamics are very different in children and adults. For the majority of drugs, in children as well as adults, a relationship exists between pharmacokinetics and pharmacodynamics. The pharmacokinetics of many drugs vary with age (Keams, 1998). For instance, because of the rapid changes in size, body composition, and organ function that occur during the first year of
[91] Prescribing medicines to older people—How to consider the impact of ... — This review article summarizes the most clinically relevant changes in human organ and body functions and the consequential changes in pharmacokinetics and pharmacodynamics in older people, along with possible dosing consequences or alternatives for drugs frequently prescribed to this patient population. This review article summarizes the most clinically relevant changes in human organ and body functions and the consequential pharmacokinetics and pharmacodynamics in older people, along with possible dosing consequences or alternatives for drugs frequently prescribed to this patient population. Drug‐related factors e.g. relate to the level of protein and tissue binding, acidity, lipophilicity, water solubility, charge and size.4 Changes in the patient body composition, including a progressive reduction in the proportion of total body water and consequently a relative increase in body fat, may alter the volume of distribution of drugs in older people.
[93] Chapter 1 Pharmacokinetics & Pharmacodynamics - Nursing Pharmacology ... — Due to the first-pass effect, prescribing providers and nurses administering medications must understand that several doses of an oral medication may be needed before enough free drug stays active in the circulation to exert the desired effect. In contrast, some drugs have an inhibitory effect on enzymes, making the client more sensitive to other medications metabolized through the action of those enzymes. Depending on whether a drug is metabolized and eliminated by the kidneys or liver, impairment in either of these systems can significantly alter medication dosing, frequency of doses, anticipated therapeutic effect, and even whether a particular medication can be used at all. These medications may require repeated dosing throughout the day in order to achieve steady blood levels of active free drug and a sustained therapeutic effect.
[94] Correlation of Pharmacokinetics, Pharmacodynamics, and ... - Springer — Drug-Drug Interactions: Pharmacokinetic and pharmacodynamic interactions between drugs can affect their efficacy and safety profiles. Pharmacokinetic interactions involve changes in the absorption, distribution, metabolism, or excretion of a drug, leading to changes in drug exposure and subsequent pharmacodynamic effects.
[95] PDF — Pharmacodynamic (PK-PD) modeling. Population pharmacokinetics involves analyzing drug concentration data from multiple individuals to characterize the typical pharmacokinetic profile of a drug and identify sources of variability such as age, gender, and disease state. This information can then be used to develop population-specific dosing
[97] Chapter 1 Pharmacokinetics & Pharmacodynamics - Nursing Pharmacology ... — Due to the first-pass effect, prescribing providers and nurses administering medications must understand that several doses of an oral medication may be needed before enough free drug stays active in the circulation to exert the desired effect. In contrast, some drugs have an inhibitory effect on enzymes, making the client more sensitive to other medications metabolized through the action of those enzymes. Depending on whether a drug is metabolized and eliminated by the kidneys or liver, impairment in either of these systems can significantly alter medication dosing, frequency of doses, anticipated therapeutic effect, and even whether a particular medication can be used at all. These medications may require repeated dosing throughout the day in order to achieve steady blood levels of active free drug and a sustained therapeutic effect.
[98] Pharmacokinetics vs Pharmacodynamics: Key Differences | KCAS Bio — By understanding both pharmacokinetics and pharmacodynamics, drug development companies can optimize drug therapies for maximum efficacy and minimal side effects. Despite these differences, pharmacokinetics and pharmacodynamics work well together in drug development. By understanding how individuals may metabolize drugs differently (pharmacokinetics) and how their bodies might respond to these drugs (pharmacodynamics), healthcare providers can customize treatments for optimal outcomes. Understanding the interplay between pharmacokinetics and pharmacodynamics is crucial for developing safe and effective drugs. Pharmacodynamics (PD) describes how drugs affect the body, influenced by factors like receptor sensitivity, drug concentration, and patient variability. Pharmacokinetics (PK) is influenced by factors like age, weight, metabolism, and liver function, which affect drug absorption, distribution, metabolism, and excretion.
[99] Chapter 1. Pharmacokinetics, Pharmacodynamics, and Principles of Drug ... — The effects of a drug—that is, the magnitude and duration of its therapeutic and adverse effects—are determined by the drug's pharmacodynamic and pharmacokinetic properties. Pharmacodynamics describes the effects of a drug on the body. Pharmacodynamic processes determine the relationship between drug concentration and response for both
[102] PDF — A. Overview of Pharmacokinetics and Pharmacodynamics Pharmacokinetics encompasses the study of drug absorption, distribution, metabolism, and excretion (ADME) within the body. Understanding these processes is crucial for predicting drug concentrations at the site of action and elucidating factors that influence drug bioavailability.
[115] How Pharmacology Research is Shaping the Next Generation of Medicines — Advances in pharmacology research are paving the way for a new generation of medicines that are not only more effective but also more targeted and personalized. As our understanding of molecular biology, genetics, and disease mechanisms continues to evolve, research is playing an increasingly pivotal role in addressing complex health challenges. From precision medicine to gene therapies
[116] Revolutionizing Personalized Medicine: Synergy with Multi-Omics Data ... — The history of personalized medicine is punctuated by significant milestones in genetics, technology, and clinical applications, shifting healthcare from a one-size-fits-all approach to a more individualized understanding of the molecular basis of health and disease and effective treatment strategies . Advances in genomics and biotechnology in the 21st century are enabling more personalized approaches to medicine, predicting disease risks, and tailoring treatments to individual genetic profiles. Personalized medicine leverages these images in conjunction with genetic data to gain deeper insights into disease mechanisms in individual patients, enhancing precision in diagnosis and treatment strategies . Through the integration of genetic, molecular, and clinical data, personalized medicine enables more accurate diagnosis, precise treatment targeting, and effective disease management.
[120] Personalized Medicine and Advancements in Pharmacology: Shaping the ... — One of the key areas in personalized medicine is genomics, which focuses on analyzing an individual’s genetic information to predict disease susceptibility, determine optimal treatment strategies, and identify potential adverse reactions.1 Pharmacogenomics, a subset of genomics, explores the relationship between an individual’s genetic variations and their response to drugs. By considering individual patient characteristics, including genetic variations, biomarkers, and clinical data, personalized medicine aims to optimize treatment efficacy, minimize adverse effects, and improve patient outcomes across diverse medical fields. Personalized medicine enables tailored treatment approaches based on individual patient characteristics, such as genetic makeup, biomarkers, and clinical data.
[126] Machine Learning in Drug Discovery: A Review - PMC - PubMed Central (PMC) — Machine learning techniques improve the decision-making in pharmaceutical data across various applications like QSAR analysis, hit discoveries, de novo drug architectures to retrieve accurate outcomes. And the AI concept is firmly related to many fields like pattern recognition, probability theory, statistics, machine learning, and numerous procedures like fuzzy models, neural networks which are collectively known as “Computational Intelligence” Vinod and Anand (2021), Engelbrecht (2007), Konar (2006), Duda et al. In drug discovery, computational intelligence provides various techniques for analyzing, learning and furthermore clarifies how such pharmaceutical was identified with AI for finding numerous medications in a programmed and integrated format (Duch et al. At last, this survey proposes AI techniques in the drug discovery area for targeting multiple applications in drug discovery and development by utilizing deep learning techniques.
[127] The future of pharmaceuticals: Artificial intelligence in drug ... — The future of pharmaceuticals: Artificial intelligence in drug discovery and development - ScienceDirect The future of pharmaceuticals: Artificial intelligence in drug discovery and development The applications of AI have been summarized in drug discovery Artificial Intelligence (AI) is revolutionizing traditional drug discovery and development models by seamlessly integrating data, computational power, and algorithms. Coupled with machine learning (ML) and deep learning (DL), AI has demonstrated significant advancements across various domains, including drug characterization, target discovery and validation, small molecule drug design, and the acceleration of clinical trials. However, AI's application in drug development faces challenges, including the need for robust data-sharing mechanisms and the establishment of more comprehensive intellectual property protections for algorithms. For all open access content, the relevant licensing terms apply.
[128] Role of Artificial Intelligence in Revolutionizing Drug Discovery — Role of Artificial Intelligence in Revolutionizing Drug Discovery - ScienceDirect Role of Artificial Intelligence in Revolutionizing Drug Discovery The application of artificial intelligence (AI) in medicine, particularly through machine learning (ML), marked a significant progression in drug discovery. This review provides an inclusive summary of the latest advancements in AI and its application in drug discovery. AI's capability to analyze extensive datasets and discern patterns is essential in these stages, enhancing predictions and efficiencies in disease identification, drug discovery, and clinical trial management. drug discovery He is the associate editor for RSC Medicinal Chemistry, editorial board member for Medicinal Research Review and other seven international journals. For all open access content, the relevant licensing terms apply.
[129] The Role of AI in Drug Discovery: Challenges, Opportunities, and ... — Artificial intelligence (AI) has the potential to revolutionize the drug discovery process, offering improved efficiency, accuracy, and speed. AI-based approaches, on the other hand, have the ability to improve the efficiency and accuracy of drug discovery processes and can lead to the development of more effective medications. By combining the predictive power of AI with the expertise and experience of human researchers , it is possible to optimize the drug discovery process and accelerate the development of new medications . Recent developments in AI, including the use of data augmentation, explainable AI, and the integration of AI with traditional experimental methods, offer promising strategies for overcoming the challenges and limitations of AI in the context of drug discovery.
[130] Integrating artificial intelligence in drug discovery and early drug ... — There are several limitations, specific to drug discovery and development in cancer, that can be summarized in the following concepts: (1) High Costs and Long Timelines: 10–15 years for a drug candidate to receive regulatory approval ; (2) Low Success Rates: approximately 90% of candidates that enter early clinical trials do not reach the market ; and (3) Complex Disease Biology: cancer involves complex, interconnected biological pathways that are difficult to target effectively with classical methods. As the main reasons for failures in drug development are insufficient efficacy and safety levels, methods based on AI could help mitigate challenges in the analysis of multiomics data by improving target identification and predicting druggability, which enhances the overall drug discovery process. An example of the integration of biological data for drug identification is PaccMann, an AI-driven framework designed to predict cancer cell sensitivity to compounds by integrating molecular structures, gene expression profiles, and protein interaction data.
[145] "Mastering Pharmaceutical Regulatory Compliance: Overcoming Challenges ... — 1. Introduction to Pharmaceutical Regulatory Compliance Pharmaceutical regulatory compliance encompasses adherence to guidelines, laws, and standards set by regulatory authorities, such as the FDA (U.S.), EMA (Europe), and CDSCO (India). These regulations aim to protect public health by ensuring that pharmaceutical products meet stringent safety and quality criteria. 2. Key Challenges in
[149] The Concept of Pharmacy Ethics and the Examples of Ethical Dilemmas ... — Modern healthcare ethics have been shaped by the bioethics concepts articulated in the Declaration of Geneva in 1948, following World War II. 4 The principles of beneficence (doing good), non-maleficence (first, do no harm), justice (equity in distribution of potential benefits and harms, as well as equity in access) and autonomy (respect for
[150] Ethics in clinical pharmacology: Facilitating public trust — The COVID-19 global pandemic setting has highlighted the role of trust in mediating relationships between experts, who design, manufacture, market and prescribe medication, and the lay public, who ingest medication. 1 Ethical interventions in science and medicine are intended to cultivate and preserve trust within the larger community. Therefore, this themed issue revolves around the timely
[151] Top 6 Ethical Controversies In The Pharmaceutical Industry — Ethical decision-making in the pharmaceutical industry is critical for balancing profit motives with patient welfare and public health concerns. The top 6 ethical controversies in the pharmaceutical industry encompass issues like drug pricing and accessibility, research practices, marketing tactics, and regulatory compliance. Drug pricing and accessibility pose significant ethical dilemmas in the pharmaceutical industry. Drug pricing practices create tension between pharmaceutical companies’ need to recover R&D costs and generate profits, and patients’ ability to afford essential treatments. Pharmaceutical patents raise complex ethical questions about balancing innovation incentives with public health needs. The pharmaceutical industry faces complex ethical challenges involving financial interests, drug pricing, patent protections, patient privacy, marketing practices, and clinical trials. What ethical issues arise from drug pricing and access to medications?
[153] Advancing Informed Consent for Vulnerable Populations - PMC — Informed consent is essential for the conduct of ethical biomedical research. 1 Despite its importance, obtaining informed consent is often a complex process, which raises concerns about the extent to which participants are truly informed. Effective implementation is especially difficult among research participants who have limited health literacy.
[154] U.S. Public Health - KFF — Public health powers and responsibilities derive from the U.S. Constitution and are shared across federal, state, and local levels of government – each of which has unique roles in such efforts that can vary state by state and even community by community. While many of public health efforts are funded and implemented through public (i.e. governmental) programs, private actors are also involved in funding and delivering public health services in the U.S. Given the many actors involved and the variations across federal, state and local roles and approaches, public health in the U.S. has often been referred to as a “patchwork” system. In the U.S., public health powers and responsibilities are shared across federal, state, and local levels of government.
[155] Access to Pharmacy | Disparities in Health and Health Care - NABP — In many communities, pharmacies are the first, and sometimes only, accessible access point for health care, especially in underserved areas. This unique positioning places pharmacists at the frontline of addressing health care disparities, though barriers like limited access to medications and the prevalence of pharmacy deserts continue to impact marginalized groups. How Pharmacoequity and Pharmacy Deserts Affect Patient Outcomes and Public Health As health care providers better understand how patient access to medications and pharmacy services are shaped by factors such as implicit bias and pharmacy deserts – areas with limited or no access to pharmacies – pharmacoequity is an increasingly important component in addressing disparities. These barriers contribute to disparities in health outcomes, as people who cannot reach or afford pharmacy care may delay or miss necessary treatments.
[157] Public Health Social Work and Policy Advocacy — Ethical Considerations in Public Health Social Work and Policy Advocacy. Public health social work and policy advocacy are critical components in addressing health disparities. These efforts promote overall well-being in communities. However, these efforts often come with ethical considerations that must be carefully navigated.
[158] The Role of Ethics in Shaping Public Health Policies - Kent — Use these four steps to assess the ethics of a public health intervention or policy. 1. Determine the public health goals of the proposed action; Identify the ethically relevant facts and uncertainties; Analyze the meaning and implications of the action for the health and rights of affected individuals and communities
[159] Advocacy for Public Health Policy Change: An Urgent Imperative - Books — The content is structured to allow the readers to go directly to the information they need when they need it. Chapter 1 is a description of how determinants of public health are values based and political and, therefore, why public policy advocacy is an essential tool for protecting and improving community health.
[160] Top 6 Ethical Controversies In The Pharmaceutical Industry — Ethical decision-making in the pharmaceutical industry is critical for balancing profit motives with patient welfare and public health concerns. The top 6 ethical controversies in the pharmaceutical industry encompass issues like drug pricing and accessibility, research practices, marketing tactics, and regulatory compliance. Drug pricing and accessibility pose significant ethical dilemmas in the pharmaceutical industry. Drug pricing practices create tension between pharmaceutical companies’ need to recover R&D costs and generate profits, and patients’ ability to afford essential treatments. Pharmaceutical patents raise complex ethical questions about balancing innovation incentives with public health needs. The pharmaceutical industry faces complex ethical challenges involving financial interests, drug pricing, patent protections, patient privacy, marketing practices, and clinical trials. What ethical issues arise from drug pricing and access to medications?
[161] Ethical Considerations In Clinical Trials: Balancing Innovation And ... — Ethical Considerations In Clinical Trials: Balancing Innovation And Patient Safety | Scientific Search This delicate equilibrium requires constant vigilance from all stakeholders, including clinical research staffing agencies, who play a crucial role in ensuring that research teams are well-equipped to address key ethical challenges such as informed consent, the use of placebos, and the handling of adverse events. The ethical challenges of informed consent, placebo use, and adverse event handling are just a few of the many dilemmas that researchers face in clinical trials. As research continues to evolve, the recruitment of knowledgeable and dedicated staff, alongside ongoing vigilance and a commitment to ethical principles, will be essential in ensuring that the pursuit of new treatments and therapies does not compromise patient safety.
[166] The Role of Pharmacology in Modern Medicine: From Drug Discovery — The Role of Pharmacology in Modern Medicine: From Drug Discovery The Role of Pharmacology in Modern Medicine: From Drug Discovery to Clinical Applications By understanding the genetic basis of drug response, healthcare providers can tailor drug therapies to individual patients, optimizing efficacy and minimizing ADRs. Pharmacology plays a vital role in modern medicine, from drug discovery to clinical applications. Pharmacology is a constantly evolving field, with new drugs and treatments being developed all the time. One of the most important developments in modern pharmacology was the use of randomized controlled trials (RCTs) to evaluate the safety and efficacy of new drugs. Pharmacology is also important in the development of new drugs.
[168] The Role of Pharmacology in Modern Medicine: From Drug Discovery — Pharmacology plays a vital role in modern medicine, from drug discovery to clinical applications. Its importance in drug development, drug safety, and personalized medicine cannot be overstated. As our understanding of the mechanisms of drug action and drug interactions continues to evolve, so too will the role of pharmacology in medicine.
[170] Pharmacogenomics Fact Sheet - National Human Genome Research Institute — Pharmacogenomics is a growing area of genomic medicine that uses a patient's genomic information to help healthcare providers select the medications and dosages that are predicted to work best in each patient. Pharmacogenomic testing involves analyzing a person’s DNA to identify genomic variants that may inform which medication or what dosage of a medication should be prescribed. Pharmacogenomics combines two scientific areas, pharmacology and genomics, to study how a person’s DNA affects their response to medications. Pharmacogenomic testing can determine whether a patient has specific genomic variants that could affect how they respond to a specific medication. Healthcare providers can test to see if a patient has one of these genomic variants in the SLCO1B1 gene, and if they do, prescribe a lower dose or a different cholesterol-lowering medication.
[171] Understanding the Role of Pharmacogenomics in Personalized Medicine — Early examples of pharmacogenomic applications included the identification of genetic variants that influenced the effectiveness of certain cancer treatments, such as the drug trastuzumab (Herceptin), used in HER2-positive breast cancer. Pharmacogenomic testing can help identify which medications are more likely to be effective based on a patient’s genetic profile. Pharmacogenomic testing can help identify genetic variations that affect drug metabolism, guiding the selection of drugs and dosages that are safer and more effective for each patient. By identifying genetic variations that influence how patients metabolize and respond to medications, pharmacogenomics offers the potential for more tailored, effective, and safer treatments. By using pharmacogenomic data, drug developers can design medications that are tailored to specific genetic profiles, increasing the likelihood that a drug will be effective across a broader range of patients.
[172] Pharmacogenomics: An evolving clinical tool for precision medicine — Patients randomized to genotype-guided treatment fared significantly better in standardized depression rating scores or response and remission rates compared with patients receiving usual clinical management.23,24 In addition to improved clinical outcomes, pharmacogenomic-guided antidepressant drug selection may also reduce healthcare resource usage and lower medication-related costs of antidepressant therapy.25 Analysis of the Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment (PREDICT) program at Vanderbilt University Medical Center found that 91% of nearly 10,000 preemptively genotyped patients had at least 1 actionable variant, and 42% of these patients had been exposed to a risk-associated medication in the past.3 If a separate test had been ordered before prescribing each of the drugs examined in this study, 14,656 tests would had to have been performed vs the 9,589 multiplex tests actually performed as part of this study, a rate 1.7 times higher.
[173] Pharmacogenetics: An Important Part of Drug Development with A Focus on ... — Sequencing the human genome brought some benefits in medicine such as early detection of diseases with a genetic predisposition, treating patients with rare diseases, the design of gene therapy and the understanding of pharmacogenetics in the metabolism of drugs. To solve this gap between research and healthcare, researchers and scientists involved in this field need to provide evidence, recommendation, and training to clinicians who lack confidence at the moment of ordering pharmacogenetic testing A physician requires broad information about the patient (integrate medicine) before prescribing a drug based on a specific biomarker . Even after recent revisions of several drug labels by the FDA, now including relevant pharmacogenetic information on them, most of these drugs are not required genetic testing before initiating therapy .
[178] Implementation of clinical practice guidelines in the healthcare ... — The literature reviewed for this concept analysis identified that implementation is a term used in many healthcare settings, but particularly relates to clinical healthcare delivery systems,27–29 quality improvement,30–32 and patient safety initiatives.33,34 The results described four important domains within the construct of implementation: 1) the practice change characteristics; 2) the guidelines or other forms of evidence which should inform the practice change; 3) strategies to implement an intervention or clinical practice guideline; and 4) the challenges and, less frequently, potential interventions to overcome these barriers.
[190] Machine Learning and AI in Clinical Trials: Use Cases — With real-world examples and case studies, we delve into how AI and ML are improving efficiency, safety, and outcomes in clinical trials, setting the stage for a future of more adaptive, patient-centric trials. In modern clinical trials, the integration of AI and ML is enhancing the efficiency and precision of trial design, enabling faster patient recruitment, real-time data analysis, and more personalized treatment approaches. AI helps overcome the challenges of clinical trial design, streamlining complex tasks such as patient selection, trial monitoring, and data analysis. In clinical trials, the integration of AI for monitoring and detecting ADEs presents significant potential for improving patient safety.
[191] Integrating artificial intelligence in drug discovery and early drug ... — There are several limitations, specific to drug discovery and development in cancer, that can be summarized in the following concepts: (1) High Costs and Long Timelines: 10–15 years for a drug candidate to receive regulatory approval ; (2) Low Success Rates: approximately 90% of candidates that enter early clinical trials do not reach the market ; and (3) Complex Disease Biology: cancer involves complex, interconnected biological pathways that are difficult to target effectively with classical methods. As the main reasons for failures in drug development are insufficient efficacy and safety levels, methods based on AI could help mitigate challenges in the analysis of multiomics data by improving target identification and predicting druggability, which enhances the overall drug discovery process. An example of the integration of biological data for drug identification is PaccMann, an AI-driven framework designed to predict cancer cell sensitivity to compounds by integrating molecular structures, gene expression profiles, and protein interaction data.
[192] Breakthrough innovations in drug delivery: How advanced materials are ... — Breakthrough innovations in drug delivery: How advanced materials are shaping future of medicine The convergence of AI and drug delivery is opening new frontiers in precision medicine. Titled "Revolutionizing Drug Delivery: The Impact of Advanced Materials Science and Technology on Precision Medicine," the review is published in Pharmaceutics. Breakthrough drug delivery systems: Nanocarriers, hydrogels, and smart polymers Bioresponsive polymers represent a significant advancement in adaptive drug delivery systems, as they can alter their properties in response to biological stimuli. The convergence of AI and drug delivery is opening new frontiers in precision medicine. By integrating AI with advanced materials, drug delivery is becoming more efficient, adaptive, and patient-specific.
[194] Nanomedicine in Infectious Diseases: Drug Delivery and Vaccines - Frontiers — Nanomedicine has made a significant impact on public health applications from developing rapid and portable diagnostics to safer and effective therapeutics for infectious diseases in particular. Recent innovations in nanomedicine have revolutionized almost every medical specialty and significantly contributed to improve the patient's life. For example, during the COVID-19 pandemic, nano
[195] Nano based drug delivery systems: recent developments and future ... — Nanotechnology offers multiple benefits in treating chronic human diseases by site-specific, and target-oriented delivery of precise medicines. The opportunities and challenges of nanomedicines in drug delivery from synthetic/natural sources to their clinical applications are also discussed. Nanotechnology is shown to bridge the barrier of biological and physical sciences by applying nanostructures and nanophases at various fields of science ; specially in nanomedicine and nano based drug delivery systems, where such particles are of major interest . Nanomedicine, is an emerging field implementing the use of knowledge and techniques of nanoscience in medical biology and disease prevention and remediation.
[196] Nanoparticle-enhanced drug delivery systems: An up-to-date review — Nanoparticle-enhanced drug delivery systems: An up-to-date review - ScienceDirect Nanoparticles (NPs) are transforming drug delivery systems (DDS), offering innovative ways to enhance drug solubility, target specific cells, and control the release of therapeutic agents. The purpose of the present review is to provide an overview of the most significant advancements in the field of nanoparticles for drug delivery systems, in terms of classification, biophysical and chemical characteristics, and targeted delivery systems. Nanoparticles are widely used in current drug delivery systems because they can help solubilize, stabilize and deliver a drug to its target site, with minimal side effects and maximum therapeutic potential. Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment A review of biodegradable natural polymer-based nanoparticles for drug delivery applications